Raptor Pharma (RPTP) CEO Won't Comment on Shire (SHPG) Bid Report, Calls it 'Rumor' - Bloomberg
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/25/2024
- Wall Street stocks fall as weak GDP growth spreads rate-cut gloom
- Q1 US GDP shows surprise slowing and uncomfortable inflation
- Alphabet (GOOGL) soars 16% on Q1 results beat, first-ever dividend
- Meta shares dip on softer Q2 revenue guidance, elevated AI spending plans
- Oil settles higher as weak U.S. economic growth offset by supply concerns
- IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
- Hasbro (HAS) brand strength sees earnings top expectations
- Meta Platforms (META) Tops Q1 EPS by 39c, Offers Guidance
- Seagate Technology (STX) Enters $600M Asset Purchase Agreement with Avago
- Rubrik (RBRK) Prices Upsized 23.5M Share IPO at $32/sh
- After-hours movers: Alphabet, Microsoft, Snap, Intel, and more
- Midday movers: Meta, IBM, Caterpillar fall; Chipotle rises
- After-hours movers: Meta, Ford, IBM, ServiceNow and more
- Midday movers: Tesla, Boeing rise; Uber, Old Dominion Freight fall
- After-hours movers: Tesla, Texas Instruments, Seagate, Visa and more
Retrophin (RTRX) Said to Consider Bid for Raptor Pharma (RPTP) - Bloomberg
August 18, 2016 6:36 AM EDTRetrophin (NASDAQ: RTRX) is considering an acquisition of Raptor Pharma (NASDAQ: RPTP), according to Bloomberg, citing sources.
Raptor has also attracted interest from other drugmakers, the report said.
... MoreRaptor Pharma (RPTP) Active on Chatter Involving Shire (SHPG)
August 17, 2016 3:13 PM EDT(Updated)
Raptor Pharma (NASDAQ: RPTP) was active Wednesday on market chatter involving takeover interest from Shire (Nasdaq: SHPG). Intereconomia.com was the source of the rumor. The offer is said to be $800 million.
... More
